T1	Participants 37 96	patients with chronic myeloid leukemia in the chronic phase
T2	Participants 233 343	patients with chronic myeloid leukemia treated by allogeneic marrow transplantation while in the chronic phase
T3	Participants 566 586	Fifty-seven patients
